Energizer cut its earnings outlook because of the consumer, not tariffs — Negative
ENR Market Watch — May 06, 2025Because of consumers' worries about the economy, the company expects lower revenue.
Tax credits can stimulate domestic movie production much more effectively than tariffs: Tom Rogers — Neutral
CMCSA DIS NFLX PARA PARAA WBD CNBC Television — May 06, 2025Tom Rogers, Claigrid executive chairman and former NBC Cable president, joins 'Squawk Box' to preview Disney's quarterly earnings results, what to expect from the media giant, President Trump's targeting of Hollywood, impact of 100% tariff on foreign films on production, and more.
Ford Q1 Earnings Surpass Expectations, Revenues Decline Y/Y — Negative
F Zacks Investment Research — May 06, 2025Ford reports higher-than-expected earnings for the first quarter and amid tariff woes, it expects an adverse adjusted EBIT impact of about $1.5 billion this year.
NVST Stock Up on Q1 Earnings and Revenue Beat, Margins Crash — Neutral
NVST Zacks Investment Research — May 06, 2025Envista delivers better-than-expected top and bottom-line results for the first quarter of 2025.
Targa Resources Q1 Earnings Miss Estimates, Expenses Increase Y/Y — Negative
TRGP Zacks Investment Research — May 06, 2025TRGP's first-quarter adjusted EBITDA totals $1.2 billion, up from $966.2 million in the prior-year period.
Ball (BALL) Beats Q1 Earnings and Revenue Estimates — Positive
BALL Zacks Investment Research — May 06, 2025Ball (BALL) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.68 per share a year ago.
Atkore Inc. (ATKR) Misses Q2 Earnings Estimates — Negative
ATKR Zacks Investment Research — May 06, 2025Atkore Inc. (ATKR) came out with quarterly earnings of $2.04 per share, missing the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $4.08 per share a year ago.
Gartner (IT) came out with quarterly earnings of $2.98 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $2.93 per share a year ago.
Knife River (KNF) Reports Q1 Loss, Tops Revenue Estimates — Negative
KNF Zacks Investment Research — May 06, 2025Knife River (KNF) came out with a quarterly loss of $1.21 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to loss of $0.84 per share a year ago.
Duke Energy (DUK) Q1 Earnings and Revenues Surpass Estimates — Positive
DUK Zacks Investment Research — May 06, 2025Duke Energy (DUK) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.44 per share a year ago.
Louisiana-Pacific (LPX) Q1 Earnings and Revenues Surpass Estimates — Positive
LPX Zacks Investment Research — May 06, 2025Louisiana-Pacific (LPX) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.53 per share a year ago.
Waters (WAT) Q1 Earnings and Revenues Beat Estimates — Positive
WAT Zacks Investment Research — May 06, 2025Waters (WAT) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.21 per share a year ago.
Leidos (LDOS) Q1 Earnings and Revenues Surpass Estimates — Positive
LDOS Zacks Investment Research — May 06, 2025Leidos (LDOS) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.29 per share a year ago.
Huntsman's Earnings In Line, Revenues Lag Estimates in Q1 — Negative
HUN Zacks Investment Research — May 06, 2025Lower average selling prices hurt HUN's Polyurethanes segment sales in the first quarter.
New Strong Sell Stocks for May 6th — Negative
AMKR BCBP FINW Zacks Investment Research — May 06, 2025AMKR, BCBP and FINW have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2025.
Cleveland-Cliffs to Post Q1 Earnings: What's in Store for the Stock? — Neutral
CLF Zacks Investment Research — May 06, 2025CLF is expected to have benefited from lower costs and higher volumes amid pricing headwinds in Q1.
What to Expect From APA Corporation's Q1 Earnings Report — Positive
APA Zacks Investment Research — May 06, 2025Strong domestic production is likely to have boosted APA's profit levels in the first quarter of 2025.
AudioCodes (AUDC) Q1 Earnings Miss Estimates — Negative
AUDC Zacks Investment Research — May 06, 2025AudioCodes (AUDC) came out with quarterly earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.17 per share a year ago.
Candel Therapeutics to Present at Upcoming Investor Conferences — Neutral
CADL GlobeNewsWire — May 06, 2025NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, announced today that management will present and participate in one-on-one meetings with investors at upcoming investor conferences.
IMUNON Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer to be Published in Gynecologic Oncology — Neutral
IMNN GlobeNewsWire — May 06, 2025Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that data from the company's Phase 1/2 OVATION 2 trial evaluating intraperitoneal IMNN-001 in combination with neoadjuvant and adjuvant chemotherapy in newly diagnosed patients with advanced epithelial ovarian cancer will be published in the peer-reviewed journal Gynecologic Oncology.
